Roxanne Taylor
Known title: DirectorCIK: 0001768759
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Unisys (UIS) Transfers $200M of Pension Obligations. Unisys moved $200 million of pension obligations onto its balance sheet, a change that could influence its financial statements. At the same time, TIME listed the company among India's best employers for 2026, underscoring its reputation as a workplace. Both items appear as the stock trades near its $2.58 support level.
Transaction History
| P | ▲ Buy | Grant | 3,515 | $0 | 6/10/2026 | View on chart |
| UIS | ▲ Buy | Grant | 82,305 | $0 | 2/27/2026 | View on chart |
| P | ▼ Sell | Open Market | 3,000 | $231K | 9/4/2025 | View on chart |
| P | ▲ Buy | Grant | 4,735 | $0 | 6/11/2025 | View on chart |
| UIS | ▲ Buy | Grant | 44,643 | $0 | 2/24/2025 | View on chart |
| P | ▼ Sell | Open Market | 8,543 | $592K | 6/18/2024 | View on chart |
| P | ▲ Buy | Grant | 4,268 | $0 | 6/12/2024 | View on chart |
| UIS | ▼ Sell | Open Market | 78,868 | $400K | 5/17/2024 | View on chart |
| P | ▼ Sell | Open Market | 36,860 | $2.0M | 4/4/2024 | View on chart |
| UIS | ▲ Buy | Grant | 36,037 | $0 | 2/26/2024 | View on chart |
| P | ▼ Sell | Open Market | 16,216 | $601K | 12/19/2023 | View on chart |
| P | ▲ Buy | Grant | 8,543 | $0 | 6/14/2023 | View on chart |
| P | ▼ Sell | Open Market | 19,155 | $500K | 4/13/2023 | View on chart |
| UIS | ▲ Buy | Grant | 40,161 | $0 | 2/28/2023 | View on chart |
| P | ▲ Buy | Grant | 9,097 | $0 | 6/15/2022 | View on chart |
| UIS | ▲ Buy | Grant | 9,187 | $0 | 2/25/2022 | View on chart |
| UIS | ▲ Buy | Grant | 1,492 | $0 | 10/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Everpure Q2 revenues up 38%, shares fall on broader S&P 500 weakness
Everpure reported a 38% surge in Q2 revenues, prompting questions about whether this growth momentum can be sustained. Despite the strong top-line results, the stock fell alongside other S&P 500 names like RUM Group and Kyndryl during the recent trading session. The company's high valuation, reflected in a trailing P/E of 173.1, may make the stock sensitive to broader market sentiment and volatility.
Everpure Q2 revenues up 38%, shares fall on broader S&P 500 weakness. Everpure reported a 38% surge in Q2 revenues, prompting questions about whether this growth momentum can be sustained. Despite the strong top-line results, the stock fell alongside other S&P 500 names like RUM Group and Kyndryl during the recent trading session. The company's high valuation, reflected in a trailing P/E of 173.1, may make the stock sensitive to broader market sentiment and volatility.